| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 7 |
| 1 | LEVOTHYROXINE SODIUM | 3 |
| 2 | CINACALCET HYDROCHLORIDE | 2 |
| 3 | ACETAMINOPHEN | 1 |
| 4 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 5 | ALLOPURINOL | 1 |
| 6 | ALPRAZOLAM | 1 |
| 7 | AMLODIPINE | 1 |
| 8 | AMLODIPINE BESYLATE | 1 |
| 9 | AMLODIPINE BESYLATE AND VALSARTAN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 1 | FERRIC CARBOXYMALTOSE | 1 | 0.0002 |
| 2 | DRONABINOL | 1 | 0.0001 |
| 3 | AMLODIPINE BESYLATE AND VALSARTAN | 1 | 0.0001 |
| 4 | SEVELAMER CARBONATE | 1 | 0.0001 |
| 5 | EPOETIN ALFA | 1 | 0.0001 |
| 6 | DOXEPIN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | PROMETHAZINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | AXITINIB | 1 | 0.0001 |
| 9 | SORAFENIB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 7 |
| 1 | Kinase Inhibitor [EPC] | 2 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 3 | Alkylating Drug [EPC] | 1 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 5 | Benzodiazepine [EPC] | 1 |
| 6 | Calcium Channel Blocker [EPC] | 1 |
| 7 | Calcium [EPC] | 1 |
| 8 | Cannabinoid [EPC] | 1 |
| 9 | Corticosteroid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cannabinoid [EPC] | 1 | 0.0001 |
| 1 | RANK Ligand Inhibitor [EPC] | 7 | 0.0000 |
| 2 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 3 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Sulfonylurea [EPC] | 1 | 0.0000 |
| 6 | Calcium [EPC] | 1 | 0.0000 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Expectorant [EPC] | 1 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 1 | 0.0000 |